Products for Research Use Only

CX-4945 sodium salt

CAT: 0607-B4903-2Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0607-B4903-2Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CK2 inhibitor
CAS Number
1309357-15-0
Product Name Alternative
5-((3-chlorocyclohexyl)amino)benzo[c][2,6]naphthyridine-8-carboxylate
Field of Research
PI3K Akt mTOR Signaling CK2
Purity
0.98
Solubility
≥44.2 mg/mL in DMSO; ≥4.45 mg/mL in EtOH with ultrasonic; ≥22.55 mg/mL in H2O with ultrasonic
Smiles
[O-]C(C1=CC=C2C(N=C(NC3CC(Cl)CCC3)C4=C2C=NC=C4)=C1)=O
Molecular Formula
C19H11ClN3NaO2
Molecular Weight
371.75
Shipping Conditions
Blue ice
Storage Conditions
Store at -20°C.

Chemical Information

Silmitasertib Sodium

Silmitasertib Sodium is the sodium salt form of silmitasertib, an orally bioavailable small-molecule inhibitor of the enzyme casein kinase II (CK2), with potential antineoplastic, anti-viral and immunomodulatory activities. Upon oral administration, silmitasertib selectively binds to and inhibits the activity of CK2. This may inhibit proliferation of CK2-expressing tumor cells, and may also inhibit the replication of severe acute respiratory syndrome coronavirus-2 (SARS-COV-2). In addition, this may restore normal host cell cytokine regulation, prevent cytokine storm and suppress the hyperactivation of the innate immune system. CK2, a protein kinase often overexpressed in a variety of cancer cell types, appears to be correlated with malignant transformation, tumor growth and survival. CK2 regulates a diverse array of pro-survival cellular processes including epidermal growth factor receptor (EGFR) signaling, PI3K/AKT/mTOR signaling, hedgehog (Hh) signaling, Hsp90 machinery, hypoxia, and interleukin (IL)-6 expression. CK2 also regulates the activity of XRCC1 and MDC1, two mediator/adaptor proteins that are essential for DNA repair. CK2 is upregulated by SARS-COV-2 and is associated with SARS-COV-2 viral replication and the development of cytokine storm.

CAS Number1309357-15-0
PubChem CID49788959
IUPAC Namesodium 5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylate
Molecular FormulaC19H11ClN3NaO2
Molecular Weight371.7
Topological Polar Surface Area77.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Heavy Atom Count26
Formal Charge0
Complexity497
SMILES
C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)[O-])C4=C2C=CN=C4.[Na+]
InChI
InChI=1S/C19H12ClN3O2.Na/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18;/h1-10H,(H,22,23)(H,24,25);/q;+1/p-1
InChIKey
ODDAAPQSODILSN-UHFFFAOYSA-M
Chemical Structure
2D Structure
2D structure of Silmitasertib Sodium
CAS: 1309357-15-0
CID: 49788959
Formula: C19H11ClN3NaO2
MW: 371.7
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight371.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count3
Exact Mass371.0437486
Monoisotopic Mass371.0437486
Topological Polar Surface Area77.9 Ų
Heavy Atom Count26
Formal Charge0
Complexity497
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes